AN UNBIASED VIEW OF LSD DRUG

Private investment into copyright pharmaceutical R&D has surged since 2018,18 supported by an FDA breakthrough therapy designation for medical trials of psilocybin for depression and copyright for PTSD. In 2021, companies invested greater than $730M in the event of copyright drugs and novel drug supply programs;19 in contrast just $4M was invested